Oslo, 18 August 2023: Reference is made to the stock exchange announcement
published earlier today, on 18 August 2023 by Navamedic ASA (the "Company" or
"Navamedic"), regarding the board of directors' resolution to increase the
Company's share capital with NOK 92,500 by the issuance of 125,000 new shares,
in order to facilitate the settlement of exercise of 125,000 share options in
the Company.

The following primary insiders have today exercised share options:

Kathrine Gamborg Andreassen, CEO of Navamedic, has today, on August 18 2023,
exercised 25,000 share options in the Company under her options agreement from
2020 and subscribed for 25,000 new shares in the Company. Following the option
exercise and subscription of the new shares, Kathrine Gamborg Andreassen holds
691 668 shares and 280,000 options in the Company.

Lars Hjarrand, CFO of Navamedic, has today, on August 18 2023, exercised 25,000
share options in the Company under his option agreements from 2019 and
subscribed for 25,000 new shares in the Company. Following the option exercise
and subscription of the new shares, Lars Hjarrand holds 285,882 shares and
250,000 options in the Company.

Astrid Bratvedt, CSO of Navamedic, has today, on August 18 2023, exercised
75,000 share options in the Company under her option agreements from 2020 and
subscribed for 75,000 new shares in the Company. Following the option exercise
and subscription of the new shares, Astrid Bratvedt holds 602,000 shares and
200,000 options in the Company.

Please refer to the attached notification of trading for further details.

This information is subject of the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.